Regentatlantic Capital LLC decreased its position in shares of Aetna Inc (NYSE:AET) by 8.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 86,901 shares of the company’s stock after selling 8,444 shares during the quarter. Aetna comprises 1.3% of Regentatlantic Capital LLC’s holdings, making the stock its 11th largest holding. Regentatlantic Capital LLC’s holdings in Aetna were worth $15,676,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Janus Henderson Group PLC grew its holdings in Aetna by 9,446.2% during the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after buying an additional 4,283,553 shares in the last quarter. Capital World Investors grew its holdings in Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares in the last quarter. Orbimed Advisors LLC grew its holdings in Aetna by 57.3% during the third quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after buying an additional 508,600 shares in the last quarter. Samlyn Capital LLC bought a new stake in Aetna during the second quarter worth $77,170,000. Finally, Point72 Asset Management L.P. grew its holdings in Aetna by 233.9% during the third quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock worth $68,271,000 after buying an additional 300,753 shares in the last quarter. Hedge funds and other institutional investors own 87.88% of the company’s stock.
Shares of Aetna Inc (NYSE:AET) traded up $1.54 during midday trading on Tuesday, hitting $189.34. The stock had a trading volume of 2,576,400 shares, compared to its average volume of 2,897,514. Aetna Inc has a 1 year low of $116.04 and a 1 year high of $192.37. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The stock has a market cap of $61,690.00, a PE ratio of 35.00, a PEG ratio of 1.59 and a beta of 0.61.
Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The firm had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same quarter in the prior year, the firm earned $2.07 EPS. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. research analysts forecast that Aetna Inc will post 9.78 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.06%. Aetna’s dividend payout ratio is presently 36.97%.
Several equities research analysts recently issued reports on the company. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and upped their price target for the stock from $195.00 to $212.00 in a report on Monday. Piper Jaffray Companies upgraded Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target for the company in a report on Wednesday, January 3rd. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Morgan Stanley downgraded Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target for the company. in a report on Wednesday, December 20th. Finally, Credit Suisse Group reiterated a “neutral” rating and set a $195.00 price target (up previously from $174.00) on shares of Aetna in a report on Wednesday, December 6th. Eleven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $175.09.
TRADEMARK VIOLATION NOTICE: “Regentatlantic Capital LLC Sells 8,444 Shares of Aetna Inc (AET)” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/23/regentatlantic-capital-llc-sells-8444-shares-of-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.